[HTML][HTML] Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases
L Recinella, G Orlando, C Ferrante… - Frontiers in …, 2020 - frontiersin.org
Besides its role as an energy storage organ, adipose tissue can be viewed as a dynamic
and complex endocrine organ, which produces and secretes several adipokines, including …
and complex endocrine organ, which produces and secretes several adipokines, including …
WNT signaling and cancer stemness
M Katoh, M Katoh - Essays in biochemistry, 2022 - portlandpress.com
Cancer stemness, defined as the self-renewal and tumor-initiation potential of cancer stem
cells (CSCs), is a cancer biology property featuring activation of CSC signaling networks …
cells (CSCs), is a cancer biology property featuring activation of CSC signaling networks …
Single Molecule Ratcheting Motion of Peptides in a Mycobacterium smegmatis Porin A (MspA) Nanopore
S Yan, J Zhang, Y Wang, W Guo, S Zhang, Y Liu… - Nano …, 2021 - ACS Publications
Diverse functions of proteins, including synthesis, catalysis, and signaling, result from their
highly variable amino acid sequences. The technology allowing for direct analysis of protein …
highly variable amino acid sequences. The technology allowing for direct analysis of protein …
[HTML][HTML] Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor …
M Katoh - International journal of oncology, 2017 - spandidos-publications.com
Cancer stem cells (CSCs), which have the potential for self-renewal, differentiation and de-
differentiation, undergo epigenetic, epithelial-mesenchymal, immunological and metabolic …
differentiation, undergo epigenetic, epithelial-mesenchymal, immunological and metabolic …
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
Prostate cancer is initially responsive to androgen deprivation, but the effectiveness of
androgen receptor (AR) inhibitors in recurrent disease is variable. Biopsy of bone …
androgen receptor (AR) inhibitors in recurrent disease is variable. Biopsy of bone …
[HTML][HTML] Cancer stem cells in progression of colorectal cancer
Y Zhou, L Xia, H Wang, L Oyang, M Su, Q Liu, J Lin… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Colorectal cancer is one of the most common cancers worldwide with high mortality. Distant
metastasis and relapse are major causes of patient death. Cancer stem cells (CSCs) play a …
metastasis and relapse are major causes of patient death. Cancer stem cells (CSCs) play a …
Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma
A Arzumanyan, HM Reis, MA Feitelson - Nature Reviews Cancer, 2013 - nature.com
Hepatocellular carcinoma (HCC) is a highly lethal cancer, with increasing worldwide
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …
FGF receptors: cancer biology and therapeutics
M Katoh, H Nakagama - Medicinal research reviews, 2014 - Wiley Online Library
Fibroblast growth factors (FGFs) are involved in a variety of cellular processes, such as
stemness, proliferation, anti‐apoptosis, drug resistance, and angiogenesis. Here, FGF …
stemness, proliferation, anti‐apoptosis, drug resistance, and angiogenesis. Here, FGF …
[HTML][HTML] Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation
M Katoh - International journal of molecular …, 2018 - build.spandidos-publications.com
Abstract β‑catenin/CTNNB1 is an intracellular scaffold protein that interacts with adhesion
molecules (E‑cadherin/CDH1, N‑cadherin/CDH2, VE‑cadherin/CDH5 and α‑catenins) …
molecules (E‑cadherin/CDH1, N‑cadherin/CDH2, VE‑cadherin/CDH5 and α‑catenins) …
[HTML][HTML] Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
Chromosomal rearrangements are initiating events in acute lymphoblastic leukaemia (ALL).
Here using RNA sequencing of 560 ALL cases, we identify rearrangements between …
Here using RNA sequencing of 560 ALL cases, we identify rearrangements between …